These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure]. Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059 [No Abstract] [Full Text] [Related]
25. [Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors]. Schute L Dtsch Med Wochenschr; 1998 Oct; 123(43):1295. PubMed ID: 9818002 [No Abstract] [Full Text] [Related]
26. Managing hypertension using combination therapy. Frank J Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493 [TBL] [Abstract][Full Text] [Related]
27. [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose]. González-Juanatey JR Med Clin (Barc); 2000; 114 Suppl 2():24-7. PubMed ID: 10916802 [TBL] [Abstract][Full Text] [Related]
33. The impact of angiotensin-converting enzyme inhibitors on managed care: economic, clinical, and humanistic outcomes. Reeder CE; Gourley GA; Wurtzbacher JD; Reed P Am J Manag Care; 2000 Feb; 6(3 Suppl):S112-28, quiz S129-31. PubMed ID: 10977441 [TBL] [Abstract][Full Text] [Related]
34. [Various ACE inhibitors are available for treatment of arterial hypertension and heart failure]. Schwartzkopff B Internist (Berl); 1993 Aug; 34(8):796. PubMed ID: 8375995 [No Abstract] [Full Text] [Related]
35. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology. Leary AC; MacDonald TM Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089 [TBL] [Abstract][Full Text] [Related]
36. Specific properties and effect of perindopril in controlling the renin-angiotensin system. Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051 [TBL] [Abstract][Full Text] [Related]
37. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. Juggi JS; Koenig-Berard E; Van Gilst WH Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428 [TBL] [Abstract][Full Text] [Related]
38. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. Schellenbaum GD; Smith NL; Heckbert SR; Lumley T; Rea TD; Furberg CD; Lyles MF; Psaty BM J Am Geriatr Soc; 2005 Nov; 53(11):1996-2000. PubMed ID: 16274385 [TBL] [Abstract][Full Text] [Related]
39. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C; Cosentino E; De Sanctis D Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921 [TBL] [Abstract][Full Text] [Related]
40. Treatment of congestive heart failure. II. Vasodilators and angiotensin-converting enzyme inhibitors. Aronow WS Ration Drug Ther; 1982 Oct; 16(10):1-5. PubMed ID: 6294740 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]